T he National Institutes of Health Stroke Scale (NIHSS) is a powerful predictor of the infarct volume and final clinical outcome. It allows for rapid clinical assessment of deficit severity in clinical practice as well as in research settings such as clinical stroke trials with high interobserver reliability. 1 Although the NIHSS's validity and clinical value in predicting stroke severity have been repeatedly shown, 1 it remains a surrogate marker that can only provide an indirect assessment of the actual brain tissue damage, which is the target of any acute stroke therapy. Accordingly, it is important to understand the relationship between NIHSS and infarct volume, as well as of factors modulating this association. This may help mitigate outcome differences in patients with stroke by improving proper assessment and guide evidence-based treatment strategies.
Leukoaraiosis is a common finding among patients with ischemic stroke, particularly if they are older and have vascular risk factors. Importantly, leukoaraiosis severity has been associated with the size of the acute ischemic tissue damage and degree of infarct expansion, as well as initial NIHSS deficit severity. [2] [3] [4] In addition, leukoaraiosis-related loss of white matter tract organization with damage to intra-and interhemispheric white matter pathways could result in reduced functional network integrity. [5] [6] [7] [8] [9] This may impair brain plasticity and compensatory mechanisms for acute deficits such that even small strokes could result in relatively large functional deficits. 10 Hence, it is conceivable that the association between infarct volume and NIHSS is affected by the degree of pre-exisiting leukoaraiosis burden.
To elucidate this issue, we sought to determine the association between the admission NIHSS and cerebral infarct volume as measured by magnetic resonance imaging (MRI) and stratified according to leukoaraiosis severity as assessed by the Fazekas scale score.
Background and Purpose-The National Institutes of Health Stroke Scale (NIHSS) provides a reliable, quantitative measure of ischemic stroke severity and is predicted by the infarct size. We sought to determine whether leukoaraiosis severity affects the association between infarct size and NIHSS. 
Methods-NIHSS and diffusion

Methods
Study Population
This study was reviewed and approved by our Institutional Review Board. We retrospectively analyzed consecutive patients with acute supratentorial ischemic stroke as shown on brain MRI that were prospectively included in our local stroke registry between January 2012 and September 2014. Patient demographics, laboratory data, comorbidities, preadmission medications, and stroke cause (using the Trial of Org 10172 in Acute Stroke Treatment classification), after completion of diagnostic evaluation, were collected on all patients. 11 NIHSS scores were assessed at the time of presentation by members of the stroke team certified in NIHSS. The modified Rankin Scale (mRS) was assessed at 90 days by a stroke-trained physician or stroke study nurse certified in mRS via in-person or phone interview. 12, 13 We adhere to the Strengthening the Reporting of Observational Studies in Epidemiology guidelines (http://www.strobe-statement.org).
Neuroimaging Protocol
Brain MRI included T1-, T2-, and fluid attenuated inversion recoverysequences, as well as diffusion-weighted images (DWI). MRI was performed on 1.5 Tesla scanner (GE Signa; GE Medical Systems, Milwaukee, WI). DWI was obtained using echo-planar imaging with a repetition time of 8000 ms, an echo time of 102 ms, a field of view of 22×22 cm, image matrix of 128×128, slice thickness 5 mm with a 1-mm gap, and b values of 0 and 1000 s/mm 2 . 14 Fluid attenuated inversion recovery was obtained with a repetition time of 9002 ms, an echo time of 143 ms, a field of view of 22×22 cm, image matrix of 256×224, and slice thickness 6 mm with a 1-mm gap. All images were evaluated by a neuroradiologist for the presence of acute ischemic infarction. Lesions that were hyperintense on DWI and hypo-or isointense on the apparent diffusion coefficient maps were considered acute ischemic infarcts. Ischemic infarcts on DWI were manually outlined using careful windowing to achieve the maximal visual extent of the acute DWI (b1000 trace-weighted) infarct and with reference to the apparent diffusion coefficient image to avoid regions of T2 shine-through and to allow for reliable distinction from leukoaraiosis. 15 Small subcortical infarcts (SSI) were defined as previously described. 16 Leukoaraiosis was defined as supratentorial white matter hyperintensity on fluid attenuated inversion recovery MRI according to the STandards for ReportIng Vascular changes on nEuroimaging criteria 17 and graded according to the Fazekas scale 18 on the basis of visual assessment both periventricular (0=absent, 1=caps or pencil lining, 2=smooth halo, and 3=irregular periventricular hyperintensities extending into deep white matter) and subcortical areas (0=absent, 1=punctuate foci, 2=beginning confluence of foci, and 3=large confluent areas). The total Fazekas score was calculated by adding the periventricular and subcortical scores. 19, 20 Perivascular spaces and lacunes of presumed vascular origin were excluded. Leukoaraiosis was separately assessed in each hemisphere, but only the score from the nonischemic hemisphere was considered after unblinding. Leukoaraiosis severity was graded according to the Fazekas scale and for statistical purposes conceptually categorized as follows: absent (0; n=44), mild (1-2; n=106), moderate (3-4; n=105), and severe (5-6; n=57). We tested inter-rater reliability of leukoaraiosis ratings in a set of 50 consecutive patients. The intraclass correlation coefficient for the total and graded Fazekas score were 0.969 (95% confidence interval, 0.943-0.983) and 0.961 (95% confidence interval, 0.932-0.978), respectively.
Image Review and Analysis
Statistics
Unless otherwise stated, continuous variables are reported as mean±SD. Categorical variables are reported as proportions.
Normality of data was examined using Shapiro-Wilk test. Betweengroup comparisons for continuous variables were made with Mann-Whitney U test and 1-way ANOVA on ranks with post hoc Dunn's method. Categorical variables were compared using the χ 2test or Fisher exact test. Correlative analyses were conducted using Spearman rank test. ANCOVA investigated whether the association between NIHSS and infarct volume differed between leukoaraiosis severity strata. Additional exploratory analyses were conducted to determine whether these associations differed between SSI and non-SSI stroke types.
To explore whether infarct volume and leukoaraiosis were independently associated with the NIHSS after adjustment for other covariates, we constructed separate preplanned incremental multivariable linear regression analyses with backward elimination to avoid overfitting (P value for elimination=0.1): First unadjusted (model 1), then adjusted for age, recombinant tissue-type plasminogen activator (r-tPA) use, admission glucose, history of stroke/transient ischemic attack, atrial fibrillation, SSI, antiplatelet, oral anticoagulant, and statin use (model 2), as well as adjusted as outlined for model 2 but with forcing age into the final model (model 3).
To achieve a more suitable distribution for ANCOVA and multivariable linear regression, we transformed not normally distributed data (NIHSS, infarct volume, and random glucose) on the basis of a cube-root transformation. 21 For ANCOVA, assumptions of homogeneity of variance and regression slopes were tested and met in all models. Collinearity diagnostics were performed (and its presence rejected) for all multivariable regression models. Two-sided significance tests were used throughout, and a 2-sided P<0.05 was considered statistically significant. All statistical analyses were performed using SPSS Statistics 22 (IBM, Armonk, NY).
Results
Study Population
During the study period, 894 patients were admitted to our stroke service with a clinical diagnosis of ischemic stroke or transient ischemic attack, 312 of whom eventually met the eligibility criteria. We excluded patients who had no MRI (n=214), no ischemic infarct (n=180), had an infratentorial infarct location (n=94), bilateral strokes (n=87), or because the admission NIHSS was not documented (n=7). Baseline characteristics of the included 312 patients as stratified by leukoaraiosis severity are summarized in Table 1 .
Univariable Associations With the Infarct Volume and NIHSS
Factors significantly correlated (Spearman ρ) with the infarct volume ( Table I in the online-only Data Supplement) were the NIHSS (r=0.591; P<0.001), random glucose at admission (r=0.141; P=0.012), history of previous stroke/transient ischemic attack (9±16 versus 20±35 mL; P=0.047), treatment with r-tPA (20±30 versus 17±33 mL; P=0.030), cardioembolic (23±34 versus 15±31 mL; P=0.003), and small-vessel disease-related stroke mechanism (1±2 versus 20±34 mL; P<0.001), SSI (irrespective of presumed stroke mechanisms; 1±2 versus 23±36 mL; P<0.001), as well as 90-day mRS (r=0.396; P<0.001).
Factors significantly correlated with the NIHSS in addition to the infarct volume were male sex (8±7 versus 6±6; P=0.001), baseline (r=0.208; P<0.001), and 90-day (r=0.556; P≤0.001) mRS; atrial fibrillation (7±6 versus 9±8; P=0.039), random glucose at admission (r=0.174; P=0.002), treatment with r-tPA (6±6 versus 9±6; P<0.001), cardioembolic (6±6 versus 9±7; P=0.001), and small-vessel disease-related stroke mechanism (8±7 versus 3±3; P<0.001), as well as SSI (irrespective of presumed stroke mechanisms; 8±7 versus 4±4; P<0.001). In additional exploratory analyses, ANCOVA demonstrated significantly different linear associations only for 
Association of the NIHSS and Infarct Volume as Stratified by Leukoaraiosis Severity
Multivariable Linear Regression Analyses
To assess whether the association between leukoaraiosis, NIHSS, and infarct volume was independent of other clinical factors, we constructed several multivariable linear Figure. A, Association between NIHSS deficit score and infarct volume of the entire cohort as shown by linear regression (small subcortical and non small subcortical infarcts are shown in separate colors for visualization purposes only). B, Same data as in A with linear regressions stratified according to leukoaraiosis severity (individual 95% prediction bands are omitted from this panel). Overall, there was a significant difference in the linear associations between cube-root NIHSS and cube-root infarct volume (P<0.001). C, Significance levels for between-group differences (ANCOVA). Note that all statistical analyses were conducted based on cube-root transformed data. However, for more easy reference with clinical observations, data shown in A and B are based on the nontransformed variables.
by guest on May 11, 2017 http://stroke.ahajournals.org/ Downloaded from regression models. These analyses demonstrated that infarct volume and leukoaraiosis severity were independently associated with the admission NIHSS in addition to intravenous r-tPA use ( Table 2 ; P<0.05). Finally, although the NIHSS is relatively protected against influences by cognitive impairment, 22, 23 we conducted sensitivity analyses restricted to patients with a prestroke mRS of 0 (n=206) to avoid potential confounding by preexisting functional deficits. This did not meaningfully change the results, and leukoaraiosis remained independently associated with the admission NIHSS (coefficient, 0.105; 95% confidence interval, 0.005-0.204; P=0.039; not shown).
Discussion
The NIHSS has been shown to correlate well with the size of the ischemic infarct, which allows for reliable assessment of stroke severity and helps inform acute decision making. 1 Recognizing factors that may modulate the association between infarct size and NIHSS is, therefore, important. For example, one of the most frequently cited reasons for exclusion of patients from treatment with intravenous thrombolysis relates to mild stroke severity, which may result in worse outcomes. 24 Conversely, an NIHSS>25 indicating severe strokes is considered a relative contraindication for r-tPA. 25 Hence, determining factors that attenuate or increase the association between infarct extent and NIHSS may improve proper initial evaluation and guide acute decision making.
Our study corroborates previous observations by demonstrating that the NIHSS is highly correlated with the infarct size. Our results are novel and important because they extend on this observation by showing that this association is attenuated with increasing burden of preexisting leukoaraiosis.
Specifically, similar sized infarcts produce greater NIHSS deficits with increasing leukoaraiosis severity and vice versa. This is consistent with the hypothesis that leukoaraiosis results in loss of white matter tract organization, 5 damage to intra-and interhemispheric white matter pathways with reduced functional network integrity, [6] [7] [8] [9] and overall reduced ability to compensate for deficits produced by an acute ischemic stroke. 7 Nevertheless, although plausible, this hypothesis will require confirmation in additional studies. Incorporation of multimodal MRI may hold particular promise to clarify issues raised by our study. For example, the combination of standard structural MRI, diffusion tensor imaging, and magnetic resonance spectroscopy may help identify and quantify the spatiotemporal extent of white matter injury and its association with functional deficit severity in patients with different degrees of leukoaraiosis severity. 6, 7 Interestingly, in our study, the impact of leukoaraiosis on the association of infarct volume and NIHSS was only present in non-SSI stroke types. This may be related to the fact that strokes in this group were more homogeneous because small-vessel disease-related strokes were excluded from this subgroup. In addition, the NIHSS is strongly weighted toward deficits of cortical origin, which may have further contributed to relatively similar scores across patients. However, the relatively small group size likely rendered this exploratory analysis underpowered to reliably assess a potential differential effect of leukoaraiosis on SSI versus non-SSI. Hence, further study including a larger sample size is required to clarify this issue.
The present study has several strengths and limitations. Strengths relate to (1) inclusion of consecutive patients with imaging confirmed, ischemic, supratentorial, stroke that were evaluated by clinicians certified in NIHSS; (2) MRIbased rating of leukoaraiosis burden; (3) blinded assessment of DWI volumes and leukoaraiosis severity with respect to clinical variables; and (4) adjustment for clinically relevant confounders.
Limitations of our study relate to the relatively small sample size and that we did not quantify leukoaraiosis burden, which may be more sensitive for detecting subtle intergroup differences and avoid a ceiling-effect in patients with severe leukoaraiosis. 26 However, the Fazekas scale is well established, frequently used in clinical research, has been shown to correlate well with the leukoaraiosis volume, and we demonstrate high inter-rater reliability of leukoaraiosis assessment. 19, 20, 26 Furthermore, using a semiquantitative approach has the advantage that it does not require intensive postprocessing routines and can thus be more easily used in the clinical setting. This may allow clinicians to quickly screen for patients based on their leukoaraiosis burden for inclusion in acute stroke protocols when there is clinical uncertainty about eligibility. Although the true clinical impact of our observations remains to be established, our results may have significant implications for guiding patient selection for endovascular stroke therapies. For example, the recent positive endovascular stroke trials had no upper age limit for inclusion. [27] [28] [29] Yet, although 2 trials showed treatment benefit at the age of ≥80 years, 26,28 confidence intervals were wide 
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indicating that in this age group patient selection needs further refinement. This is further underscored by the fact that higher age and admission NIHSS predict worse outcomes after endovascular therapy, 30 and-most important to the present study-patients aged >80 years may only benefit from endovascular stroke therapy when their ischemic core volume is lower than that of younger patients. 31 In this respect, our results provide a biologically plausible rationale (1) as to why older patients (who are more likely to have leukoaraiosis) may tolerate only relatively smaller infarcts and (2) that leukoaraiosis may be considered a marker of biological age that could improve on standard chronological age-based inclusion criteria. Nevertheless, given the retrospective nature of our study, results should be considered hypothesis generating only and not guide clinical decision making at this point. A further limitation relates to the fact that we did not have information available on prestroke motor and cognitive performance. However, as previously stated, the NIHSS is relatively protected against influences by cognitive impairment, 22, 23 and analyses restricted to patients with a prestroke mRS=0 did not meaningfully change our results. Together, this assuages concerns that our results were biased by preexisting deficits. Finally, although our results demonstrate a strong association between leukoaraiosis and the infarct-NIHSS relation, a causal relationship remains to be fully established.
Conclusions
Despite its limitations, our observations strongly suggest that the severity of preexisting leukoaraiosis significantly modulates the association between infarct volume and functional deficit severity. Although the clinical impact of our findings needs further exploration, the results may have significant implications for future research to improve patient selection for acute stroke therapies.
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